Polymer Capital Management’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,688
Closed -$204K 1036
2026
Q1
$204K Buy
+11,688
New +$225K 0.02% 737

Other funds holding BIOA

Polymer Capital Management's BIOA Position: Q2 2026 in Review

Polymer Capital Management sold out of BioAge Labs (BIOA) in Q2 2026, closing a stake of 11,688 shares — an estimated $204K sold.

Polymer Capital Management first reported a position in BIOA in Q1 2026 and held it in 1 quarter. The position peaked at $204K in Q1 2026. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Polymer Capital Management reported no remaining BioAge Labs position as of Q2 2026 after selling out during the quarter.
  • Polymer Capital Management sold 11,688 BioAge Labs shares in Q2 2026, an estimated $204K.
  • Polymer Capital Management first reported a position in BioAge Labs in Q1 2026 and held it in 1 quarter.
  • Polymer Capital Management's BioAge Labs position peaked at $204K in Q1 2026.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.